Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Aledort

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Safety|November 22, 2018
Evaluating the safety of emicizumab in patients with hemophilia AArielle L Langer, Aaron Etra, Louis Aledort
Journal of Managed Care & Specialty Pharmacy|April 1, 2020
A Retrospective Observational Study of Rurioctocog Alfa Pegol in Clinical Practice in the United StatesLouis Aledort, Scott Milligan, Maureen Watt, et al.
Expert Review of Hematology|March 9, 2023
New directions to develop therapies for people with hemophiliaPooja Gogia, Michael Tarantino, Wolfgang Schramm, et al.
Expert Review of Hematology|April 11, 2014
Factor VIII therapy for hemophilia A: current and future issuesLouis Aledort, Rolf Ljung, Kenneth Mann, et al.
Blood Transfusion = Trasfusione Del Sangue|December 18, 2019
Factor VIII replacement is still the standard of care in haemophilia ALouis Aledort, Pier Mannuccio Mannucci, Wolfgang Schramm, et al.
American Journal of Hematology|March 17, 2010
Manifestations of superwarfarin ingestion: a plea to increase awarenessDipika Misra, Myron Bednar, Caroline Cromwell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 8, 2011
Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP)Miguel A Sanz, Louis Aledort, Susan D Mathias, et al.
The American Journal of Gastroenterology|January 26, 2002
Bleeding diathesis in amyloidosis with renal insufficiency associated with Crohn's disease: response to desmopressinSandeep P Dave, Adrian J Greenstein, David B Sachar, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 14, 2019
Why plasma-derived factor VIII?Louis Aledort, Shannon L Carpenter, Adam Cuker, et al.
Neurocritical Care|March 28, 2014
Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhageJennifer A Frontera, Errol Gordon, Victor Zach, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Safety|November 22, 2018
Evaluating the safety of emicizumab in patients with hemophilia AArielle L Langer, Aaron Etra, Louis Aledort
Journal of Managed Care & Specialty Pharmacy|April 1, 2020
A Retrospective Observational Study of Rurioctocog Alfa Pegol in Clinical Practice in the United StatesLouis Aledort, Scott Milligan, Maureen Watt, et al.
Expert Review of Hematology|March 9, 2023
New directions to develop therapies for people with hemophiliaPooja Gogia, Michael Tarantino, Wolfgang Schramm, et al.
Expert Review of Hematology|April 11, 2014
Factor VIII therapy for hemophilia A: current and future issuesLouis Aledort, Rolf Ljung, Kenneth Mann, et al.
Blood Transfusion = Trasfusione Del Sangue|December 18, 2019
Factor VIII replacement is still the standard of care in haemophilia ALouis Aledort, Pier Mannuccio Mannucci, Wolfgang Schramm, et al.
American Journal of Hematology|March 17, 2010
Manifestations of superwarfarin ingestion: a plea to increase awarenessDipika Misra, Myron Bednar, Caroline Cromwell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 8, 2011
Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP)Miguel A Sanz, Louis Aledort, Susan D Mathias, et al.
The American Journal of Gastroenterology|January 26, 2002
Bleeding diathesis in amyloidosis with renal insufficiency associated with Crohn's disease: response to desmopressinSandeep P Dave, Adrian J Greenstein, David B Sachar, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 14, 2019
Why plasma-derived factor VIII?Louis Aledort, Shannon L Carpenter, Adam Cuker, et al.
Neurocritical Care|March 28, 2014
Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhageJennifer A Frontera, Errol Gordon, Victor Zach, et al.
Pageof 3